IntegraGen SA announced earnings results for the year ended Dec. 31, 2017. For the year, revenues were EUR 6,247,000, operating loss was EUR 1,930,000, current loss was EUR 1,450,000 and net loss was EUR 863,000 against revenues of EUR 6,022,000, operating loss of EUR 1,801,000, current loss of EUR 1,759,000 and net loss of EUR 1,651,000 a year ago. Exceptional profit was EUR 254,000 against loss of EUR 162,000 a year ago.

The company anticipates genomic services business will continue to grow in 2018, driven by the increase in orders it witnessed in 2017 and with sequencing offers integrating the provision of new software tools. The 12% increase in orders in 2017 should result in a corresponding revenue growth in 2018.